Price Summary

On 2026-10-19, Eli Lilly and Company's stock opened at 1243.39, peaked at 1259.75, hit a low of 1239.1, and closed -0.25% lower at 1240.34, with 1959500 shares changing hands.
The peak price for the stock in the past 52 weeks is 1280.34, with the lowest price being 0.0.

Technicals

Support and Resistance: The current price sits at 1240.34, supported at 1229.93 and capped by resistance at 1280.34. These levels define a range for LLY where the price might stabilize, with 1229.93 as a floor and 1280.34 as a ceiling.

Aroon: The AROON is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.

Bol. Bands: The BOLL BANDS is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.

Parabolic SAR: The PSAR remains bullish in its outlook, setting a key support level that could sustain the ongoing upward trend. This strong support indicates that the market may continue to rise, with the bullish momentum likely to persist for LLY.

Stochastic: The stochastic indicator reflects bullish conditions for LLY, with the K-line above both the D-line and the 80 level. This setup suggests strong upward momentum, implying that the market may continue to experience gains. Investors could interpret this as a sign of ongoing strength.

Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.

The technical analysis of a company's stock performance is valuable, but only when considered in conjunction with the company's fundamentals. These fundamentals, including financial strength, earnings growth, and leadership, provide a foundation for understanding market movements. Additionally, industry trends and competitive pressures play an important role. By integrating both fundamental and technical analysis, one can better evaluate the company's true potential and make more informed investment decisions.